Lymphoplasmacytic lymphoma surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Surgery is not the first-line treatment option for patients with lymphoplasmacytic lymphoma. [[Stem cell transplant]] is usually reserved for patients with either relapse or refractory lymphoplasmacytic lymphoma.
[[Surgery]] is not the [[first-line treatment]] option for patients with [[lymphoplasmacytic lymphoma]]. [[Stem cell transplant]] is usually reserved for patients with either [[relapse]] or [[refractory]] [[lymphoplasmacytic lymphoma]].


==Surgery==
==Surgery==
*[[Stem cell transplant]] is usually reserved for patients when either lymphoma comes back (recurs/relapses) after treatment or doesn’t respond to other treatments (called refractory disease).<ref name="sure">Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref>
*[[Stem cell transplant]] is usually reserved for patients when either [[lymphoma]] comes back (recurs/relapses) after treatment or doesn’t respond to other treatments (called refractory [[disease]]).<ref name="sure">Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref>
*Many people with lymphoplasmacytic lymphoma are older or may not be in good health, so a stem cell transplant may not be a good treatment option for them.
*Many people with [[lymphoplasmacytic lymphoma]] are older or may not be in good health, so a [[stem cell transplant]] may not be a good treatment option for them.


==References==
==References==

Revision as of 22:39, 19 February 2019

Lymphoplasmacytic lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphoplasmacytic Lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphoplasmacytic lymphoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphoplasmacytic lymphoma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphoplasmacytic lymphoma surgery

CDC on Lymphoplasmacytic lymphoma surgery

Lymphoplasmacytic lymphoma surgery in the news

Blogs on Lymphoplasmacytic lymphoma surgery

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Lymphoplasmacytic lymphoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Overview

Surgery is not the first-line treatment option for patients with lymphoplasmacytic lymphoma. Stem cell transplant is usually reserved for patients with either relapse or refractory lymphoplasmacytic lymphoma.

Surgery

References

  1. Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015

Template:WH Template:WS